Recent data from the Centers for Disease Control and Prevention have shown a concerning trend in the rise of sexually transmitted infections (STIs) in older adults. Contrary to popular belief, it is not just the younger generation that is at risk for these infections. The number of people over the age of 65 diagnosed with chlamydia, gonorrhea, and syphilis has increased significantly in the United States. This increase has been particularly alarming, with a three-, five- and sevenfold rise in diagnoses, respectively, from 2010 to 2023.
Several factors have been identified as potential reasons for the prevalence of STIs in older adults. One explanation is the limited understanding of STIs in this age group, leading to misconceptions and lack of awareness. Additionally, the reluctance of older adults to discuss their sexual history with partners and healthcare providers contributes to the misconception that they are sexually inactive or monogamous. Furthermore, the increased availability of medications such as Viagra, Cialis, and estrogen creams has led to more sexual activity in older adults, increasing their risk of STIs.
Research has shown that postmenopausal women are particularly vulnerable to STIs due to biological changes that occur during menopause. Menopause is a stage in a woman’s life marked by the cessation of menstrual periods, typically occurring between the ages of 45 and 55. It is estimated that by 2030, 1.2 billion women worldwide will be postmenopausal. Menopause results in a loss of estrogen production from the ovaries, leading to conditions such as genitourinary syndrome of menopause (GSM), which can cause vaginal dryness, irritation, and increased susceptibility to infections.
Recent studies have shown that menopause can compromise the structural integrity of the tissue lining the vagina, making postmenopausal women more prone to infections. The proteins desmoglein-1 (DSG1) and desmocollin-1 (DSC1), which strengthen the vaginal lining and limit pathogen access, are significantly reduced in postmenopausal women. This reduction in proteins makes postmenopausal women more susceptible to infections such as herpes simplex virus type 2 (HSV-2) and chlamydia.
While more research is needed to fully understand the impact of menopause on STI susceptibility in older adults, preliminary findings suggest that estrogen-containing compounds used to alleviate symptoms of GSM may also reduce vulnerability to STIs. For instance, applying estrogen cream has been shown to restore the integrity of the vaginal lining in postmenopausal mice, protecting them from HSV-2 infection. In the meantime, healthcare providers play a crucial role in reducing the risk of STIs in older adults by educating them about safe sex practices and offering routine STI screening.
The rising rates of STIs among older adults highlight the need for increased awareness, research, and preventive measures in this demographic. By addressing both the behavioral and biological risk factors contributing to STI susceptibility, we can work towards reducing the prevalence of these infections in older adults and improving their overall sexual health.
Leave a Reply